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Abstract
Objective -To compare the costs ofseveral proposed methods of screening for cystic fibrosis.
Setting -England and Wales. Methods -The costs of screening carried out at hospital antenatal clinics, general practitioner (GP) antenatal consultations, GP surgeries, and at work were estimated using data from demonstration projects. Couple screening, stepwise screening, and screening of individuals were considered. Results -Couple screening at antenatal hospital clinics was the least expensive per carrier couple detected, amounting to £35 700 (£142 900 for each potential cystic fibrosis fetus detected). The costs of the reagents (£25 per test) accounted for over 60% of this total. Conclusions -Antenatal screening, in addition to being the most cost effective method of screening, is also medically the screening method of choice as it provides information at the latest time when effective preventive action can be taken and at a time when all people to be screened are likely to be accessible.
If the costs of the reagents could be reduced to £5 (still higher than the costs of most diagnostic reagents) the cost for each pregnant carrier couple offered screening would be reduced by 50% to about £18 000, and the cost ofoffering screening to 684 000 pregnant couples in England and Wales would be about~m instead of £19m. (Joumal of Medical Screening 1995; 2:22-27) Keywords: cost analysis, cystic fibrosis.
Cystic fibrosis (CF) screening is now possible as about 85% of carriers of a CF mutation in a community can be identified. Demonstration projects have confirmed its acceptability. Cystic fibrosis screening aims at providing individuals with the opportunity of avoiding the birth of a child with CF, either by a carrier deciding not to have a child with another carrier or else by having prenatal diagnosis and an abortion if necessary. Several different methods of achieving this have been proposed: screening couples at antenatal clinics, screening couples before conception, or screening individuals.
The main focus of this paper is to compare the costs ofthese various screening methods for each "relevant" carrier couple, relevant couples being those who, in the absence of knowledge about their CF carrier status, are planning to have a child. We used the 1994 costs for each procedure associated with the different methods of screening. The subsequent discussion emphasises that the choice of screening method is not exclusively a matter of finance; but, fortunately, in this case there seems to be no significant conflict between medical and financial considerations.
Methods
Projects using the following different methods of screening for cystic fibrosis have been reported:
(a) both couple and stepwise screening at a hospital antenatal clinic (b) both couple and stepwise screening at an antenatal consultation with the general practitioner (GP) (c) screening by GPs of individuals aged 18-40 using various different methods of contacting them, ranging from personal letters to information in the waiting room (d) offering screening at work (e) "cascade" testing for CF, in which the relatives of CF carriers are sought and tested.
The costs of cascade testing for CF are not considered here as both the ethics and methodology involved in the screening process are completely different and simply comparing relative costs is inappropriate. Screening school children has been proposed, but is not considered here as there is no evidence that this confers a benefit in the general community. There are no immediate options that the children can take and by the time they reach maturity it is debatable as to how accurately their carrier status will be remembered or recorded. An exception is the Dor Yeshurim scheme among orthodox Jews, in which the carrier status of the children is recorded and referred to before marriage introductions are arranged. Neonatal screening is also not considered.
Methods (c) and (d) are aimed at individuals, but for individuals to know their carrier status is of limited value and may actually be detrimental. Therefore, we have used the observed uptake rates from these projects to estimate uptake rates if the screening methods in (c) were alternatively aimed only at couples.
In screening couples the cost of offering screening to 10 000 people and their partners, if necessary, is estimated. When screening individuals, in order for both partners in a possible 10 000 couples to have been screened, it is necessary to screen 20 000 individuals. Table 1 provides expanded details of these costs.
Therefore the cost of offering screening to 20 000 individuals is calculated. COSTS Some or all of the following procedures constitute the total costs of the screening methods considered:
PREVALENCE OF CF MUTATION
We have taken it that one in 25 people carry the CF gene in England and Wales and that about 85% of carriers can be detected. I Therefore the expected number of carriers detected is 340 per 10 000 people tested, and the expected number of carrier couples detected is 12 per 10 000 couples tested.
THE DIFFERENT SCREENING METHODS
1 Couple screening at hospital antenatal clinic Method a 3 4 A leaflet is included in the booking clinic appointment sent to each woman explaining CF and CF screening. Couples are told that they will be tested only if both members agree to take part. If they wish to be screened a buccal sample is obtained from both parents at the initial visit by scraping the inside cheek lining. If the father is not present, a buccal smear is taken from the mother, and the father is later asked for a buccal smear, which is sent to the laboratory by post. One sample is tested. If the sample does not reveal a CF mutation the second is not tested. Ifit does the other sample is tested. If a CF mutation is identified the couple is screen positive. Negative results are not notified. Screen positive couples are notified by telephone and referred to a consultant for counselling and possible antenatal diagnosis. The observed uptake rate was 67%.34
Estimating an upper limit to the number of couplesplanning to have a child When individuals are screened we assume they will all eventually be in a couple planning to have a child. When couples are screened we assume all couples screened are planning to have a child.
sumptions have to be made about whether an individual will ever be in a couple planning to have a child. The sets of assumptions made here are extreme in order to given an indication of the possible range of costs. Note that in all methods we consider only one pregnancynamely, the current one in the case of those already pregnant and the next one in the case ofthose not pregnant. The probability ofhaving further children is not considered.
Estimating a lower limit to the number of couples planning to have a child
If family sizes by woman's age in 1988 and projected family sizes 1a z are used, 40% of women aged 17-38 will have at least one more child. Therefore in screening individuals or couples aged 18--40 we assume that only 40% will be in a couple planning to have a child. £0.50 £5.00 £0.50 £0.10 £25.00 (i) 5-10 minute session to obtain consent to screening for CF (possibly given during a routine appointment made for some other reason or else by a health care professional in the GP's surgery) leaflet giving information about CF and about being a carrier for CF one universal tube reagents needed to analyse one sample (v) laboratory and administration costs of analysing one sample and reporting results (including an additional 40% to allow for overheads) £14.00 sending a letter or making a phone call to report the test results one counselling session discussing positive test results with the woman and advising her to persuade her partner to be tested in stepwise screening, probably lasting about 10--15 minutes £10.00 one counselling session discussing positive test results with the couple, probably lasting about 30-40 minutes:
£30.00
The aim in CF screening is to provide carrier couples with the opportunity of avoiding having a child with cystic fibrosis by deciding (a) not to form a couple or (b) not to have children, or else (c) to have prenatal diagnosis and an abortion ifnecessary. The main outcome measure is the number of "relevant" carrier couples identified, relevant couples being those who, in the absence of knowledge about their CF carrier status, are planning to have a child. For the antenatal screening methods the woman is already pregnant, and therefore by definition is in a couple planning to have a child (the unborn fetus). In all the other methods as-
Method b 5 6
This method is the same as the previous method (a), except that two universal containers are included with the letter containing the booking clinic appointment and the explanatory leaflet. Couples are told that they will be tested only if both members agree to take part and each provides a mouthwash sample. The samples are collected at the clinic, and if one or both samples are forgotten the couple is asked to send them later. One sample is tested. If the sample reveals a CF mutation the other sample is tested. Negative results are not notified. Screen positive couples are notified by telephone and referred to a consultant for counselling and possible antenatal diagnosis. The observed uptake rate was 69'4%.56
2 Stepwise screening at hospital antenatal clinic 6 This method is similar to couple screening at a hospital antenatal clinic, apart from the fact that the woman only is tested first, and if she is found positive she is contacted, counselled, and the partner is then invited for screening. The observed uptake rates were 72'9% for women and 99·1 % for men whose partners tested positive."
3 Couple screening at GP antenatal consultation 7 Screening is explained and offered at the time of antenatal booking consultation. The sample is taken from the woman agreeing to screening during the consultation and she is given a kit for the father. No action is taken unless the sample is returned from the father. One sample is tested. If the sample is positive the other sample is tested. Negative results are not notified. Positive results are notified by telephone and referred to a consultant for counselling and possible prenatal diagnosis. In a reported study 86·8% of women offered screening agreed, but 6% of men did not return their samples, resulting in an estimated uptake rate of 81· 6%. 7 4 Stepwise screeningat GP antenatal consultation 7 This method is similar to couple screening at GP antenatal consultation, apart from the fact that the woman is tested first and if found positive is contacted and counselled to invite the partner for screening. He is then tested. The estimated observed uptake rate was 86·8% for women and 100% for men whose partners tested positive,"
5 GPs sending invitations for screening individuals 8 9 A personally addressed letter and information leaflet is sent to both men and women aged between 18 and 40 inviting them to make an appointment for screening. The test is explained during the appointment and the sample is collected and sent to the laboratory for analysis. Positive results are notified by post with an explanatory leaflet, and the patient is offered an appointment for genetic counselling. An estimated uptake rate of 9·9% was calculated by taking a weighted average of the rates in two studiesr"
6 Encouraging patients in GP surgeries to have screenint 9 Patients waiting in GP surgeries are approached, told about CF screening, and offered immediate testing. As above, positive results are notified by post with an explanatory leaflet, and the patient is offered an appointment for genetic counselling. An estimated uptake rate Morris, Oppenheimer of 68'2% was calculated by taking a weighted average of the rates in two 9tUdies. n 7 GPs sending invitations for screening to couples This proposed method has not been carried out. A personally addressed letter and information leaflet is sent to both men and women aged between 18 and 40 inviting all patients who are part of a couple planning to have children to make an appointment with their partner for screening. In the costing it is assumed that couples registered with the same doctor would receive two invitations. The test is explained during the appointment and the sample is collected from both parents. If only one partner is present a universal container is supplied and the absent partner is asked to send the buccal smear by post. The samples are sent to the laboratory for analysis. One sample is tested. If the sample shows a CF mutation the other sample is tested. Screen positive couples are notified by telephone and are offered an appointment for genetic counselling. It is estimated that the uptake rate will be similar to that observed for method 5, screening individuals -that is, 9·9%.
Encouraging couples in GP surgeries to have screening
This proposed method has not been carried out. Patients waiting in GP surgeries are approached and asked if they are in a couple. If so they are told about CF screening and offered immediate testing. A universal container is supplied and the absent partner is asked to send the smear by post. The samples are sent to the laboratory for analysis. One sample is tested.
If the sample shows a CF mutation the other sample is tested. Screen positive couples are notified by telephone and are offered an appointment for genetic counselling. It is estimated that the uptake rate will be similar to that observed for method 6, screening individuals -that is, 68·2%.
9 Offering screening to individuals at work l O Posters advertising CF screening are displayed in the workplace. People responding are offered private interviews during which they are given a leaflet explaining CF screening and are offered immediate testing. Test results are notified in writing with a copy for them to pass on to their GPs. The observed uptake rate was 20%.10
Several other methods of GPs contacting individuals have been reported." 911 The above methods have been illustrated in detail as they have the most extreme uptake rates, and also the most extreme costs. Table 1 gives the estimated costs for each procedure used in screening one couple or two individuals. The cost for each couple actually tested is least for couple screening occurring at antenatal hospital clinics at £41.31 for method (a). (Costs of £41.80 for method (b) are not reported in detail here as they are similar to those for method (a)). The cost for each couple offered screening is least for screening, in which GPs send their patients letters, but this is owing to the extremely low response rate (9'9%), which means that for many couples the expense of actually testing (as opposed to inviting) is not incurred. Table 2 gives the estimated overall costs expressed for different outcome measures. The outcome measure of primary importance is the cost for each relevant CF carrier couple detected. Also for interest's sake the cost for each potential CF fetus identified is calculated. Couple screening at antenatal hospital clinics is the least expensive at £35700 (or £36200 for method (b)) for each relevant CF carrier couple detected. In all the procedures for screening at hospital antenatal clinics the laboratory costs account for over 95% of the total costs, with the costs of reagents alone accounting for 60%.
Results

SENSITIVITY ANALYSIS
Finally, because tables 1 and 2 are based on various assumptions, table 3 shows the effect of changing the assumptions about uptake rates, laboratory costs, costs of overheads, and coun-. selling costs. Note that in stepwise screening only the woman's uptake rates have been decreased by 5%. It has been assumed that partners of women found to be carriers will have the same high uptake rates. Decreasing the uptake rates by 5% increases the costs for each relevant carrier couple detected by less than 1% for the antenatal screening methods. The decrease in uptake rates has a much greater effect in the methods requiring screening by GPs before pregnancy, with the cost increasing by over 23% for the method of screening in which GPs send a letter to the couples. This is because this method has high costs for contacting people and persuading them to have the test.
A £5 increase in the cost of reagents has the same effect as a 100% increase in laboratory overheads; that is an increase in the range of 7-11 % for most methods. A 100% increase in counselling costs, increases the total costs by less than 1% for all methods. Table 3 also shows the effect of reducing the cost of reagents to £5, nearer the costs of most diagnostic reagents. This reduces the costs of hospital antenatal couple screening by over 50%.
Discussion
Couple screening at hospital antenatal clinics is the least expensive for each relevant carrier couple detected. It must be emphasised here that financial considerations are only part of the assessment of the screening method of choice. For a screening programme to be worthwhile it needs to provide the screen positive people with an option that is exercised in a reasonable number of cases. Offering people Morris, Oppenheimer an option that is never exercised is a waste of time and resources. The only advantage in principle of screening individuals instead of couples is that it might cause them to restrict their choice of future partner. In practice this seems unlikely to occur. Knowledge of one's carrier status may even be deleterious. The advantage of screening couples before pregnancy rather than at antenatal clinicis is that they could decide either to adopt a child instead of having their own biological child or not to have a family, but again there is no evidence that these options would be exercised to any material extent. It is debatable whether it is also preferable for a couple to learn about their carrier status before pregnancy when no decision about prenatal diagnosis can be made. An advantage of antenatal screening is that in all pregnancies the mother will attend an antenatal clinic, either at the GP surgery or else at the hospital. It is much harder to locate couples who are planning, but have not yet started, a family, particularly as many pregnancies are unplanned. Moreover, any options affecting the longer term future depend on individuals retaining the information accurately and on subsequent medical professionals accepting its validity.
The main advantage of couple screening over stepwise screening is that in stepwise screening 97% of women who are told they are screen positive will have a screen negative partner, some of whom will be a carrier of a mutation not at present detectable. These women are thus exposed to a slight degree of anxiety as they are at a slightly increased risk of an affected pregnancy, but no diagnostic test is available to resolve the uncertainty. This is avoided in couple screening, as screen positive individuals with screen negative partners are not informed of their status. Couple screening does have the disadvantage that the results only relate to that particular couple; if one partner forms a new relationship then the new couple needs to be tested. This is unlikely significantly to increase the costs. Only 2·1 % of families with children contain children from both previous and current partners." If half of lone mother families containing two or more children have children from different fathers, this would result in a further 4% of all families. 14 When all the factors are taken into account couple screening in antenatal clinics is medically the screening method of choice, and our analysis shows that it is also the most cost effective.
Couple screening at hospital antenatal clinics is less expensive than couple screening at the GP antenatal consultation. An advantage of screening by GPs, however, is that it will take place slightly earlier. The uptake rate is also higher. The choice of hospital or GP screening will also depend on local circumstances. For instance, in America some pregnant women will self refer to obstetricians; not all of them will be referred through the GP as in England.
The cost of the reagents (£25 per test) accounts for over 60% ofthe total costs ofhospital antenatal couple screening. If the cost of the reagents could be reduced to £5, still higher than the costs of most diagnostic reagents, the cost for each pregnant carrier couple would be reduced by 50% to about £18000, and the cost of offering screening to 684 000 pregnancies in England and Wales would be about £9~m instead of £19m. Such a reduction may be needed to make general antenatal screening a practical proposition.
